Viral Platforms and Synthetic Nanoparticles in Transforming CAR-T Cell Therapy: A Review of Recent Experimental Advances in Enhancing Safety and Efficacy

{"Chimeric":[0],"antigen":[1,179],"receptor":[2,180],"T-cell":[3,156,181],"(CAR-T)":[4],"therapy":[5],"represents":[6],"a":[7,30,95],"transformative":[8],"breakthrough":[9],"in":[10,107,171,221],"the":[11,41,49,78,87,139,148,161,167,194,208],"treatment":[12],"of":[13,44,51,65,80,91,150,197,201,210],"hematological":[14],"malignancies.However,":[15],"its":[16],"clinical":[17],"efficacy":[18,90],"against":[19],"solid":[20],"tumors":[21],"is":[22],"greatly":[23],"hindered":[24],"by":[25,127],"physical":[26],"stromal":[27],"barriers":[28],"and":[29,48,75,82,89,103,137,158,176,193,219],"complex,":[31],"immunosuppressive":[32],"tumor":[33],"microenvironment":[34],"(TME).In":[35],"addition":[36],"to":[37,69,85,131,154,163],"these":[38,202],"biological":[39],"hurdles,":[40],"high":[42],"cost":[43],"ex":[45,99],"vivo":[46,100,108,172],"manufacturing":[47],"risk":[50],"severe":[52],"adverse":[53],"effects,":[54],"such":[55,205],"as":[56,120],"cytokine":[57],"release":[58],"syndrome,":[59],"limit":[60],"widespread":[61],"patient":[62],"access.The":[63],"aim":[64],"this":[66],"review":[67,112,168],"was":[68],"analyze":[70],"reports":[71],"published":[72],"between":[73],"2020":[74],"2025":[76],"regarding":[77],"use":[79],"viral":[81,132],"synthetic":[83],"nanoplatforms":[84],"improve":[86,216],"safety":[88,218],"CAR-T":[92,109,125],"therapy,":[93],"with":[94,142],"particular":[96],"focus":[97],"on":[98],"cell":[101,110,135],"engineering":[102,126],"innovative":[104],"strategies":[105],"for":[106],"generation.The":[111],"first":[113],"evaluates":[114],"how":[115],"lipid-and":[116],"polymer-based":[117],"nanoparticles,":[118],"acting":[119],"nonviral":[121],"vectors,":[122],"can":[123],"revolutionize":[124],"providing":[128],"cost-effective":[129],"alternatives":[130],"transduction,":[133],"accelerating":[134],"preparation,":[136],"minimizing":[138],"risks":[140],"associated":[141],"random":[143],"genomic":[144],"integration.It":[145],"then":[146],"examines":[147],"application":[149],"multifunctional":[151],"nanocatalysts":[152],"designed":[153],"enhance":[155],"infiltration":[157],"actively":[159],"modulate":[160],"TME":[162],"overcome":[164],"immune":[165],"evasion.Crucially,":[166],"explores":[169],"cutting-edge":[170],"platforms,":[173],"including":[174],"VivoVec":[175],"adaptable":[177],"chimeric":[178],"(AdCAR-T)":[182],"systems,":[183],"which":[184],"facilitate":[185],"direct":[186],"endogenous":[187],"lymphocyte":[188],"reprogramming,":[189],"thus":[190],"bypassing":[191],"lymphodepletion":[192],"logistical":[195],"burdens":[196],"specialized":[198],"laboratory":[199],"processing.Integration":[200],"nanotechnologies":[203],"into":[204],"workflows":[206],"enables":[207],"development":[209],"\\"smart,\\"":[211],"controllable":[212],"therapeutic":[213],"systems":[214],"that":[215],"both":[217],"scalability":[220],"personalized":[222],"oncology.":[223]}